Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of clascoterone solution for male pattern hair loss (androgenetic alopecia) is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Clascoterone Solution (clascoterone)

Snippet

Sponsor: Cassiopea SpA | Conditions: Alopecia, Androgenetic | Phase 3 | Status: ACTIVE_NOT_RECRUITING